Agilon Health, Inc. logo AGL - Agilon Health, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 8
HOLD 14
SELL 3
STRONG
SELL 0
| PRICE TARGET: $84.71 DETAILS
HIGH: $141.00
LOW: $16.00
MEDIAN: $111.00
CONSENSUS: $84.71
DOWNSIDE: 12.47%

Stock News

agilon health: The Q2 Inflection Is Real

agilon health: The Q2 Inflection Is Real

agilon Health delivered a strong Q2 2026 with revenue of $1.49B, a $250M YoY medical margin swing, and raised FY26 guidance across all key metrics. AGL's operational turnaround is supported by improved cost trends, enhanced data pipelines, and clinical pathway execution, notably reducing inpatient first-diagnosis rates from 25% to under 5%. Balance sheet strength is evident with over $220M net cash, while disciplined membership management supports ongoing profitability.

Aug 07, 2026 06:07 AM • seekingalpha.com
agilon health Reports Second Quarter 2026 Results

agilon health Reports Second Quarter 2026 Results

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the second quarter ended June 30, 2026. In addition, the company increased full-year 2026 guidance for total revenues, medical margin, and Adjusted EBITDA. “Our second quarter results exceeded our expectations, demonstrating meaningful progress across agilon's strategic initiatives and reinforcing our confidence i.

Aug 05, 2026 12:05 PM • businesswire.com
Kaskela Law Firm Announces Investigation of Agilon Health, Inc. (AGL) and Encourages Long-Term AGL Shareholders with Investment Losses to Contact the Firm

Kaskela Law Firm Announces Investigation of Agilon Health, Inc. (AGL) and Encourages Long-Term AGL Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Agilon Health, Inc. (NYSE: AGL) (“Agilon”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/case/agilon-health/ Recently a securities fraud complaint was filed against Agilon on behalf of certain investors who purchased shares of the company's stock between April 15, 2021 and February 27, 2024. According to the complaint, during that.

Jul 23, 2026 03:00 AM • businesswire.com
agilon health Reports ACO REACH Model Results for 2024 Performance Year

agilon health Reports ACO REACH Model Results for 2024 Performance Year

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $229 million in gross savings (13.6% gross savings rate), including $54 million savings in the Medicare Trust Fund, during the 2024 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon's eight REACH ACOs operate under full risk, a.

Jul 10, 2026 04:30 AM • businesswire.com
agilon health Sets Date to Report Second Quarter 2026 Financial Results

agilon health Sets Date to Report Second Quarter 2026 Financial Results

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the second quarter 2026 after market close on Wednesday, August 5, 2026 and host a conference call at 4:30 p.m. ET to discuss the results. The conference call can be accessed by dialing (833) 439-1904 for U.S. participants and +1 (585) 542-9983 for international participants and refe.

Jul 07, 2026 12:05 PM • businesswire.com
agilon health: Q1 Inflection And A New CEO Set Up A Multi-Year Rerating

agilon health: Q1 Inflection And A New CEO Set Up A Multi-Year Rerating

agilon health is rated Buy with a $177 price target, reflecting a robust Q1 beat and a positive inflection in financials. Q1 2026 delivered $1.42B revenue (+$40M vs. consensus), $54M adjusted EBITDA (+162% YoY), and raised full-year guidance across all key metrics. Margin expansion is driven by a new data pipeline, scaled clinical programs, disciplined payer contracting, and AI-driven risk scoring now fully operational.

Jun 23, 2026 10:40 PM • seekingalpha.com
agilon health to Participate in Upcoming Conferences

agilon health to Participate in Upcoming Conferences

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that members of its management team will participate in investor meetings and industry discussions at the following conferences: Truist Securities Healthcare Disruptors & Digital Health Conference on Tuesday, June 23, 2026 in New York. Management will participate in an ACO Model panel discussion at 1:50pm ET and conduct o.

Jun 09, 2026 12:05 PM • businesswire.com

Price Targets